A single-molecule characterisation of ALS-FTSD neuropathology to identify biomarkers of clinical heterogeneity

Project Details

StatusActive
Effective start/end date1/04/23 → 30/09/26

Funding

  • Motor Neurone Disease Association: £257,736.68